Thursday, 6 February 2025
  
Login

Australia's most trusted
source of pharma news

Thursday, 06 February 2025
News

Top fastest growing PBS drugs

Posted 4 February 2025 AM

The Top 35 PBS drugs with the biggest growth cost the Federal Government an extra $1.4 billion over the last financial year (FY), according to Expenditure and Prescriptions Report 2023-24.

Despite continuing supply issues, sales of Novo Nordisk's GLP-1 agonist Ozempic skyrocketed 94 per cent in the 2023-24 FY, costing the government an extra $138.5 million compared to the previous FY.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (5)

Sales & Customer Relations (20)

Clinical & Medical, R&D (9)

Regulatory, Pharmacovigilance & QA (4)

Other (16)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.